Geographical variation of Crohn's disease residual incidence in the Province of Quebec, Canada

International Journal of Health Geographics

Volumn 9, Issue , 2010, Pages

  Michel, Pascal ^a,b   St Onge, Laurie ^a   Lowe, Anne Marie ^b   Bigras Poulin, Michel ^b   Brassard, Paul ^b,c  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE INCIDENCE; DISEASE SPREAD; ETIOLOGY; GASTROENTERITIS; GEOGRAPHICAL VARIATION; METROPOLITAN AREA; REGRESSION ANALYSIS;

CANADA; MONTREAL; QUEBEC [CANADA];

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; COMPARATIVE STUDY; CROHN DISEASE; DEMOGRAPHY; ENVIRONMENTAL EXPOSURE; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; PREDICTION AND FORECASTING; PROBABILITY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; STATISTICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CROHN DISEASE; DEMOGRAPHY; ENVIRONMENTAL EXPOSURE; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; PREDICTIVE VALUE OF TESTS; PROBABILITY; QUEBEC; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; YOUNG ADULT;

EID: 77951979959     PISSN: None     EISSN: 1476072X     Source Type: Journal    
DOI: 10.1186/1476-072X-9-22     Document Type: Article

References (48)

1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006, 12(Suppl 1):S3-S9. 10.1097/01.MIB.0000195385.19268.68, 16378007.
2. Shanahan F, Bernstein CN. The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 2009, 25:301-305. 10.1097/MOG.0b013e32832b12ef, 19349861.
3. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006, 101:1559-1568. 10.1111/j.1572-0241.2006.00603.x, 16863561.
4. Aamodt G, Bukholm G, Jahnsen J, Moum B, Vatn MH. The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am J Epidemiol 2008, 168:1065-1072. 10.1093/aje/kwn218, 18801890.
5. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999, 149:916-924.
6. Aamodt G, Jahnsen J, Bengtson MB, Moum B, Vatn MH. Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993. Inflamm Bowel Dis 2008, 14:984-991. 10.1002/ibd.20417, 18338775.
7. Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001, 154:328-335. 10.1093/aje/154.4.328, 11495856.
8. Nerich V, Monnet E, Etienne A, Louafi S, Ramee C, Rican S, Weill A, Vallier N, Vanbockstael V, Auleley GR, Allemand H, Carbonnel F. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 2006, 12:218-226. 10.1097/01.MIB.0000206540.38834.8c, 16534424.
9. Sincic BM, Vucelic B, Persic M, Brncic N, Erzen DJ, Radakovic B, Micovic V, Stimac D. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: A prospective population-based study. Scand J Gastroenterol 2006, 41:437-444. 10.1080/00365520500320094, 16635912.
10. Green C, Elliott L, Beaudoin C, Bernstein CN. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 2006, 164:615-623. 10.1093/aje/kwj260, 16920784.
11. Lowe AM, Roy PO, Poulin M, Michel P, Bitton A, St Onge L, Brassard P. Epidemiology of Crohn's disease in Quebec, Canada. Inflamm Bowel Dis 2009, 15:429-435. 10.1002/ibd.20756, 18942744.
12. Régie de l'assurance maladie du Québec. Statistiques annuelles. 2000,
13. Ayanian JZ. Using administrative data to assess health care outcomes. Eur Heart J 1999, 20:1689-1691. 10.1053/euhj.1999.1823, 10562474.
14. Monfared AA, Lelorier J. Accuracy and validity of using medical claims data to identify episodes of hospitalizations in patients with COPD. Pharmacoepidemiol Drug Saf 2006, 15:19-29. 10.1002/pds.1131, 16136613.
15. Anselin L. Local indicators of spatial association - LISA. Geographical Analysis 1995, 27:93-115.
16. Elliott P, Savitz DA. Design issues in small-area studies of environment and health. Environ Health Perspect 2008, 116:1098-1104. 10.1289/ehp.10817, 2516594, 18709174.
17. Kanauchi O, Mitsuyama K, Andoh A. The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Curr Pharm Des 2009, 15:2074-2086. 10.2174/138161209788489195, 19519445.
18. Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol 2009, 15:2570-2578. 10.3748/wjg.15.2570, 2691486, 19496185.
19. Lucendo AJ, De Rezende LC. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol 2009, 15:2081-2088. 10.3748/wjg.15.2081, 2678578, 19418580.
20. Goh K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis 2009, 10:1-6. 10.1111/j.1751-2980.2008.00355.x, 19236540.
21. Li X, Sundquist J, Sundquist K. Educational level and occupation as risk factors for inflammatory bowel diseases: A nationwide study based on hospitalizations in Sweden. Inflamm Bowel Dis 2009, 15:608-615. 10.1002/ibd.20815, 19067408.
22. Jiang L, Xia B, Li J, Ye M, Yan W, Deng C, Ding Y, Luo H, Hou W, Zhao Q, Liu N, Ren H, Hou X, Xu H. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 2006, 12:212-217. 10.1097/01.MIB.0000201098.26450.ae, 16534423.
23. Cucino C, Sonnenberg A. Occupational mortality from inflammatory bowel disease in the United States 1991-1996. Am J Gastroenterol 2001, 96:1101-1105.
24. Van Den BJ, Cahill J, Emmanuel AV, Vaizey CJ, Talbot IC, Knight SC, Kamm MA. Gut mucosal response to food antigens in Crohn's disease. Aliment Pharmacol Ther 2002, 16:1903-1915. 10.1046/j.1365-2036.2002.01360.x, 12390099.
25. Mekkel G, Barta Z, Ress Z, Gyimesi E, Sipka S, Zeher M. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases]. Orv Hetil 2005, 146:797-802.
26. Joseph AJ, George B, Pulimood AB, Seshadri MS, Chacko A. 25 (OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity. Indian J Med Res 2009, 130:133-137.
27. Peyrin-Biroulet L, Oussalah A, Bigard MA. Crohn's disease: the hot hypothesis. Med Hypotheses 2009, 73:94-96. 10.1016/j.mehy.2009.01.022, 19269107.
28. Pineton D, Colombel JF, Poulain D, Darfeuille-Michaud A. Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol 2008, 24:440-447. 10.1097/MOG.0b013e3283023be5, 18622157.
29. Behr MA, Kapur V. The evidence for Mycobacterium paratuberculosis in Crohn's disease. Curr Opin Gastroenterol 2008, 24:17-21. 10.1097/MOG.0b013e3282f1dcc4, 18043227.
30. Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001, 154:328-335. 10.1093/aje/154.4.328, 11495856.
31. Noomen CG, Hommes DW, Fidder HH. Update on genetics in inflammatory disease. Best Pract Res Clin Gastroenterol 2009, 23:233-243. 10.1016/j.bpg.2009.02.005, 19414149.
32. Laberge AM. [Prevalence and distribution of genetic diseases in Quebec: impact of the past on the present]. Med Sci (Paris) 2007, 23:997-1001.
33. Laberge AM, Michaud J, Richter A, Lemyre E, Lambert M, Brais B, Mitchell GA. Population history and its impact on medical genetics in Quebec. Clin Genet 2005, 68:287-301. 10.1111/j.1399-0004.2005.00497.x, 16143014.
34. Moreau C, Vezina H, Yotova V, Hamon R, de Knijff P, Sinnett D, Labuda D. Genetic heterogeneity in regional populations of Quebec--parental lineages in the Gaspe Peninsula. Am J Phys Anthropol 2009, 139:512-522. 10.1002/ajpa.21012, 19226649.
35. Bhat M, Nguyen GC, Pare P, Lahaie R, Deslandres C, Bernard EJ, Aumais G, Jobin G, Wild G, Cohen A, Langelier D, Brant S, Dassopoulos T, McGovern D, Torres E, Duerr R, Regueiro M, Silverberg MS, Steinhart H, Griffiths AM, Elkadri A, Cho J, Proctor D, Goyette P, Rioux J, Bitton A. Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository. Am J Gastroenterol 2009, 104:2233-2240. 10.1038/ajg.2009.267, 2742627, 19513023.
36. Scriver CR. Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2001, 2(69-101):69-101. 10.1146/annurev.genom.2.1.69, 11701644.
37. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006, 101:1559-1568. 10.1111/j.1572-0241.2006.00603.x, 16863561.
38. Green C, Elliott L, Beaudoin C, Bernstein CN. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 2006, 164:615-623. 10.1093/aje/kwj260, 16920784.
39. Aamodt G, Jahnsen J, Bengtson MB, Moum B, Vatn MH. Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993. Inflamm Bowel Dis 2008, 14:984-991. 10.1002/ibd.20417, 18338775.
40. Sincic BM, Vucelic B, Persic M, Brncic N, Erzen DJ, Radakovic B, Micovic V, Stimac D. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: A prospective population-based study. Scand J Gastroenterol 2006, 41:437-444. 10.1080/00365520500320094, 16635912.
41. Declercq C, Gower-Rousseau C, Vernier-Massouille G, Salleron J, Balde M, Poirier G, Lerebours E, Dupas JL, Merle V, Marti R, Duhamel A, Cortot A, Salomez JL. Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluence. Inflamm Bowel Dis 2010, 16:804-806. 10.1002/ibd.21111, 19753639.
42. Button LA, Roberts SE, Goldacre MJ, Akbari A, Rodgers SE, Williams JG. Hospitalized prevalence and 5-year mortality for IBD: record linkage study. World J Gastroenterol 2010, 16:431-438. 10.3748/wjg.v16.i4.431, 2811794, 20101767.
43. Skrzydlo-Radomanska B, Radwan P, Radwan-Kwiatek K. Retrospective analysis of hospital admissions of patients with ulcerative colitis and Crohn's disease from semi-rural and rural regions in the Department of Gastroenterology in Lublin between 2000- 2006. Ann Agric Environ Med 2008, 15:193-197.
44. Aamodt G, Bukholm G, Jahnsen J, Moum B, Vatn MH. The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am J Epidemiol 2008, 168:1065-1072. 10.1093/aje/kwn218, 18801890.
45. Hildebrand H, Malmborg P, Askling J, Ekbom A, Montgomery SM. Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease. Scand J Gastroenterol 2008, 43:961-966. 10.1080/00365520801971736, 19086166.
46. Asakura H, Suzuki K, Kitahora T, Morizane T. Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis?. J Gastroenterol Hepatol 2008, 23:1794-1801. 10.1111/j.1440-1746.2008.05681.x, 19120872.
47. Rothman KJ, Greenland S. Precision and Validity in Epidemiologic Studies. Modern Epidemiology 1998, Lippincot; Raven, Rothman KJ, Greenland S, 2.
48. McKnight J, Scott A, Menzies D, Bourbeau J, Blais L, Lemiere C. A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol 2005, 58:206-208. 10.1016/j.jclinepi.2004.08.006, 15680756.